Welcome to our dedicated page for Celanese Del SEC filings (Ticker: CE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Celanese Corporation (NYSE: CE) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures, including Form 8-K current reports and other documents filed with the U.S. Securities and Exchange Commission. Celanese is a global specialty materials and chemical company in the basic organic chemical manufacturing industry, and its filings offer detailed insight into its financing activities, governance developments and operational decisions.
Recent Form 8-K filings describe a range of material events. Several filings outline registered offerings of senior notes by Celanese US Holdings LLC, a wholly owned subsidiary, including 7.000% Senior Notes due 2031 and 7.375% Senior Notes due 2034. These filings explain that net proceeds are used to repay borrowings under a five-year term loan credit agreement due 2027, fund cash tender offers for outstanding senior notes due 2027 and 2028, and support general corporate purposes, which may include repayment of other indebtedness.
Other 8-K reports cover cash tender offers for the company’s 6.665% Senior Notes due 2027 and 6.850% Senior Notes due 2028, including announcements of the commencement of tender offers, early results and increases in the maximum tender amount and series cap. Additional filings detail a revolving credit agreement providing a five-year unsecured revolving credit facility and an amendment to an existing term loan credit agreement, including new covenant terms.
Celanese filings also document operational and portfolio actions, such as the intended closure of an acetate tow production facility in Lanaken, Belgium, with associated expected non-cash accelerated depreciation and other shutdown costs, and the signing of a purchase and sale agreement to divest the Micromax® portfolio of products. Governance-related filings include the resignation of a Board member and the company’s explanation that the departure was not due to any disagreement on operations, policies or practices.
On Stock Titan, these SEC filings are presented with real-time updates from EDGAR and AI-powered summaries that help explain the key points of each document. Users can quickly understand the implications of Celanese’s 8-K disclosures, senior note offerings, credit agreements, tender offers and other reported events without reading every technical detail.
Celanese Corporation reported improved profitability for the three months ended March 31, 2026. Net sales were $2,337 million, slightly below $2,389 million a year earlier, but operating profit rose to $214 million from $165 million as mix and one‑time items helped margins.
Net earnings attributable to Celanese were $44 million, compared with a loss of $24 million, and diluted earnings per share moved to $0.40 from a loss of $0.22. Results benefited from a $50 million gain on the sale of the Micromax business and higher equity earnings, partially offset by $20 million of restructuring charges and higher interest expense of $183 million.
Operating cash flow increased to $76 million, while investing inflows of $425 million were driven by $493 million of proceeds from the Micromax divestiture. Cash and cash equivalents rose to $1,758 million and long-term debt including current installments stood at $12,599 million, reflecting a leveraged but liquid balance sheet.
Celanese Corporation reported first quarter 2026 adjusted earnings per share of $0.85, reflecting solid execution in a weak demand environment. Engineered Materials delivered adjusted EBIT of $220 million and operating EBITDA of $324 million, helped by favorable mix, cost reductions and value‑based pricing.
The Acetyl Chain generated adjusted EBIT of $131 million and operating EBITDA of $194 million, with late‑quarter supply disruptions creating high‑value pricing opportunities that are expected to benefit second quarter results. Company‑wide free cash flow was $3 million, an improvement versus typical seasonal cash use.
Management raised its full‑year 2026 free cash flow target to $700–$800 million and continues to prioritize deleveraging, with net debt of $10.8 billion at quarter‑end and plans to repay roughly $900 million of bonds in the second and third quarters. For the second quarter, Celanese guides to adjusted EPS of $2.00–$2.40, driven primarily by stronger Acetyl Chain earnings, and expects second quarter to be the highest‑earning quarter of 2026.
Celanese Corporation reported first quarter 2026 adjusted earnings per share of $0.85, reflecting solid execution in a weak demand environment. Engineered Materials delivered adjusted EBIT of $220 million and operating EBITDA of $324 million, helped by favorable mix, cost reductions and value‑based pricing.
The Acetyl Chain generated adjusted EBIT of $131 million and operating EBITDA of $194 million, with late‑quarter supply disruptions creating high‑value pricing opportunities that are expected to benefit second quarter results. Company‑wide free cash flow was $3 million, an improvement versus typical seasonal cash use.
Management raised its full‑year 2026 free cash flow target to $700–$800 million and continues to prioritize deleveraging, with net debt of $10.8 billion at quarter‑end and plans to repay roughly $900 million of bonds in the second and third quarters. For the second quarter, Celanese guides to adjusted EPS of $2.00–$2.40, driven primarily by stronger Acetyl Chain earnings, and expects second quarter to be the highest‑earning quarter of 2026.
Celanese Corporation reported stronger first quarter 2026 results, with improving earnings and cash flow. U.S. GAAP diluted EPS from continuing operations was $0.41 and adjusted EPS was $0.85. Net sales were $2.34 billion, up 6% sequentially, driven mainly by 5% higher volumes.
Engineered Materials delivered $1.3 billion of net sales and operating EBITDA of $324 million, with margins of 25%. The Acetyl Chain generated $1.0 billion of net sales and $194 million of operating EBITDA at a 19% margin. Companywide operating EBITDA reached $455 million.
Free cash flow was modest at $3 million, reflecting seasonal working capital and timing of interest payments, but management raised its full‑year free cash flow outlook to $700–$800 million and targets a net debt to operating EBITDA ratio near 4.8x. The company also outlined Q2 2026 adjusted EPS guidance of $2.00–$2.40 and projected about $3.00 of adjusted EPS in the second half of 2026.
Celanese Corporation reported stronger first quarter 2026 results, with improving earnings and cash flow. U.S. GAAP diluted EPS from continuing operations was $0.41 and adjusted EPS was $0.85. Net sales were $2.34 billion, up 6% sequentially, driven mainly by 5% higher volumes.
Engineered Materials delivered $1.3 billion of net sales and operating EBITDA of $324 million, with margins of 25%. The Acetyl Chain generated $1.0 billion of net sales and $194 million of operating EBITDA at a 19% margin. Companywide operating EBITDA reached $455 million.
Free cash flow was modest at $3 million, reflecting seasonal working capital and timing of interest payments, but management raised its full‑year free cash flow outlook to $700–$800 million and targets a net debt to operating EBITDA ratio near 4.8x. The company also outlined Q2 2026 adjusted EPS guidance of $2.00–$2.40 and projected about $3.00 of adjusted EPS in the second half of 2026.
Celanese Corp reports Vanguard Capital Management beneficial ownership of 5,774,130 shares of Common Stock. The filing shows 5.15% of the class and discloses sole dispositive power for 5,774,130 shares and sole voting power for 827,850 shares. The statement attributes holdings to Vanguard Capital Management and several Vanguard affiliates.
Vanguard Portfolio Management reports beneficial ownership of 6,332,554 shares of Celanese Corp common stock, representing 5.65% of the class. The filing states sole voting power of 60,872 shares and sole dispositive power of 6,332,554. The filing notes these holdings include securities held by Vanguard funds and certain affiliates over which Vanguard Portfolio Management exercises dispositive power. Signature block shows the filing was signed on 04/29/2026.
Celanese Corp director Anne P. Noonan has filed an initial Form 3 reporting her beneficial ownership in the company’s common stock. The filing shows she holds 0 shares of Common Stock directly following the reported position as of April 20, 2026.
Celanese Corporation expanded its Board of Directors from nine to 10 members and elected Anne P. Noonan as a director, effective April 20, 2026. She will serve until the 2027 Annual Meeting of Shareholders, when she is expected to stand for election by shareholders.
The Board determined that Ms. Noonan is an independent director under SEC and NYSE standards and is not related to any company officers or directors. A former CEO of Summit Materials and OMNOVA Solutions with more than 30 years of industry experience, she will receive standard non-management director compensation.
Celanese Corporation reported the results of its 2026 Annual Meeting of Shareholders. Nine director nominees were elected to terms expiring at the 2027 annual meeting, each receiving strong support, with votes for individual nominees generally exceeding 91.6 million shares.
Shareholders ratified the selection of KPMG LLP as independent registered public accounting firm for 2026, with 97,496,875 votes for and limited opposition. An advisory vote on executive compensation also passed, receiving 91,098,487 votes for versus 1,766,137 against. Of 111,922,758 shares entitled to vote as of February 23, 2026, 99,090,064 were represented in person or by proxy, reflecting an 88.53% quorum.
Celanese Corp Schedule 13G/A amendment: The Vanguard Group reports 0 shares beneficially owned, representing 0% of Common Stock, following an internal realignment. The filing states disaggregated reporting in accordance with SEC Release No. 34-39538 (January 12, 1998). Signed by Ashley Grim on 03/26/2026.
Celanese Corporation and Celanese US Holdings LLC filed a Form S-3 shelf registration on March 25, 2026 to register one or more classes of securities for offering from time to time after the registration statement is declared effective. The prospectus describes common stock, preferred stock, debt securities and guarantees and states that specific terms, aggregate amounts and offering prices will be set forth in prospectus supplements.
The filing identifies certain wholly owned subsidiaries as potential guarantors and discloses authorized capital figures as of February 24, 2026 including 400,000,000 authorized common shares, 170,920,036 issued and 109,571,972 outstanding. The shelf is filed by Celanese as a "well-known seasoned issuer" and permits continuous or delayed offerings under supplemental prospectuses.